Novonesis
404.8
DKK
+0.27 %
NSIS B
NASDAQ Copenhagen
Biotechnology & Pharmaceuticals
Health Care
20 following
+0.27%
+1.56%
-11.89%
-8.56%
+9.08%
+11.52%
-22.57%
+26.86%
+994.05%
Novonesis is a biochemistry company. The company develops enzymes and various microorganisms for industrial use. The enzymes are a protein used in a number of different industries, mainly in the agricultural and food industries. Novonesis products are used in various foods and clothing and the company holds sales on a global level. Novonesis was founded in 1921 and is headquartered in Bagsværd, Denmark.
Read moreMarket cap
189.57B DKK
Turnover
566.61M DKK
Revenue
17.9B
EBIT %
22.21 %
P/E
37.07
Dividend yield-%
1.53 %
Financial calendar
26.2
2025
Annual report '24
3.4
2025
General meeting '24
13.8
2025
Interim report Q2'25
ShowingAll content types
Major shareholder announcement
Major shareholder announcement
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools